Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Endometrial Cancer Therapeutics Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4492444
  • 120 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Endometrial Cancer Therapeutics in recent years and the growth of consumers' demand is expected to drive the global Endometrial Cancer Therapeutics market.

Geographically, the global Endometrial Cancer Therapeutics market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Endometrial Cancer Therapeutics market in North America.

Significant participants active in the global Endometrial Cancer Therapeutics market include: Eli Lilly and Company, F. Hoffman La Roche Ltd., CELGENE, Merck KGaA, ArQule, Inc., Teva Pharmaceutical Industries, Bayer AG, Sanofi, Janssen Pharmaceuticals, Pfizer, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis...

Global Endometrial Cancer Therapeutics Market Segmentation:

Endometrial Cancer Therapeutics market, by Endometrial Cancer Therapeutics type:

Chemotherapy

Hormone Therapy

Radiation Therapy

Surgery

Endometrial Cancer Therapeutics market, by Application:

Research Institutes

Hospitals & Clinics

Endometrial Cancer Therapeutics Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Endometrial Cancer Therapeutics by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Endometrial Cancer Therapeutics Market-Segmentation

4.1 By Type

4.1.1 Chemotherapy

4.1.2 Hormone Therapy

4.1.3 Radiation Therapy

4.1.4 Surgery

4.2 By End-User/Application Industry

4.2.1 Research Institutes

4.2.2 Hospitals & Clinics

4.3 By Geography

4.3.1 North America Endometrial Cancer Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Endometrial Cancer Therapeutics Production from 2014-2020

4.3.1.2 North America Endometrial Cancer Therapeutics Consumption from 2014-2020

4.3.1.3 North America Endometrial Cancer Therapeutics Import and Export from 2014-2020

4.3.1.4 North America Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Endometrial Cancer Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Endometrial Cancer Therapeutics Production from 2014-2020

4.3.2.2 Europe Endometrial Cancer Therapeutics Consumption from 2014-2020

4.3.2.3 Europe Endometrial Cancer Therapeutics Import and Export from 2014-2020

4.3.2.4 Europe Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Endometrial Cancer Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Endometrial Cancer Therapeutics Production from 2014-2020

4.3.3.2 Asia-Pacific Endometrial Cancer Therapeutics Consumption from 2014-2020

4.3.3.3 Asia-Pacific Endometrial Cancer Therapeutics Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Endometrial Cancer Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Endometrial Cancer Therapeutics Production from 2014-2020

4.3.4.2 Latin America Endometrial Cancer Therapeutics Consumption from 2014-2020

4.3.4.3 Latin America Endometrial Cancer Therapeutics Import and Export from 2014-2020

4.3.4.4 Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Endometrial Cancer Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Endometrial Cancer Therapeutics Production from 2014-2020

4.3.5.2 Middle East & Africa Endometrial Cancer Therapeutics Consumption from 2014-2020

4.3.5.3 Middle East & Africa Endometrial Cancer Therapeutics Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Eli Lilly and Company

5.1.1 Eli Lilly and Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2014-2020

5.2 F. Hoffman La Roche Ltd.

5.2.1 F. Hoffman La Roche Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 F. Hoffman La Roche Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.3 CELGENE

5.3.1 CELGENE Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 CELGENE Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Merck KGaA

5.4.1 Merck KGaA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Merck KGaA Sales, Growth Rate and Global Market Share from 2014-2020

5.5 ArQule, Inc.

5.5.1 ArQule, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 ArQule, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Teva Pharmaceutical Industries

5.6.1 Teva Pharmaceutical Industries Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Teva Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Bayer AG

5.7.1 Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Bayer AG Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Sanofi

5.8.1 Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Sanofi Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Janssen Pharmaceuticals

5.9.1 Janssen Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Janssen Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Pfizer

5.10.1 Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2020

5.11 Bristol-Myers Squibb Company

5.11.1 Bristol-Myers Squibb Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.11.2 Bristol-Myers Squibb Company Sales, Growth Rate and Global Market Share from 2014-2020

5.12 Takeda Pharmaceutical Company Limited

5.12.1 Takeda Pharmaceutical Company Limited Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.12.2 Takeda Pharmaceutical Company Limited Sales, Growth Rate and Global Market Share from 2014-2020

5.13 GlaxoSmithKline plc

5.13.1 GlaxoSmithKline plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.13.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2014-2020

5.14 Novartis

5.14.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.14.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Endometrial Cancer Therapeutics Market from 2021-2026

7.1 Future Forecast of Global Endometrial Cancer Therapeutics Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Endometrial Cancer Therapeutics Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Endometrial Cancer Therapeutics Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Endometrial Cancer Therapeutics Market Value ($) and Growth Rate of Endometrial Cancer Therapeutics from 2014-2026

Global Endometrial Cancer Therapeutics Production and Growth Rate Segment by Product Types from 2014-2026F

Global Endometrial Cancer Therapeutics Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Endometrial Cancer Therapeutics Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Endometrial Cancer Therapeutics Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Chemotherapy of Endometrial Cancer Therapeutics

Figure Hormone Therapy of Endometrial Cancer Therapeutics

Figure Radiation Therapy of Endometrial Cancer Therapeutics

Figure Surgery of Endometrial Cancer Therapeutics

Table Global Endometrial Cancer Therapeutics Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Endometrial Cancer Therapeutics Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Research Institutes of Endometrial Cancer Therapeutics

Figure Hospitals & Clinics of Endometrial Cancer Therapeutics

Table Global Endometrial Cancer Therapeutics Production Value ($) by Regions

Table Global Endometrial Cancer Therapeutics Production Value Share by Regions

Table Global Endometrial Cancer Therapeutics Production by Regions

Table Global Endometrial Cancer Therapeutics Production Share by Regions

Table Global Endometrial Cancer Therapeutics Consumption by Regions

Table Global Endometrial Cancer Therapeutics Consumption Share by Regions

Figure North America Endometrial Cancer Therapeutics Production and Growth Rate from 2014-2020

Figure North America Endometrial Cancer Therapeutics Consumption and Growth Rate from 2014-2020

Table North America Endometrial Cancer Therapeutics Import and Export from 2014-2020

Table North America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

Table North America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

Table North America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

Figure Europe Endometrial Cancer Therapeutics Production and Growth Rate from 2014-2020

Figure Europe Endometrial Cancer Therapeutics Consumption and Growth Rate from 2014-2020

Table Europe Endometrial Cancer Therapeutics Import and Export from 2014-2020

Table Europe Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

Table Europe Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

Table Europe Endometrial Cancer Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Endometrial Cancer Therapeutics Production and Growth Rate from 2014-2020

Figure Asia-Pacific Endometrial Cancer Therapeutics Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Endometrial Cancer Therapeutics Import and Export from 2014-2020

Table Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

Figure Latin America Endometrial Cancer Therapeutics Production and Growth Rate from 2014-2020

Figure Latin America Endometrial Cancer Therapeutics Consumption and Growth Rate from 2014-2020

Table Latin America Endometrial Cancer Therapeutics Import and Export from 2014-2020

Table Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Endometrial Cancer Therapeutics Production and Growth Rate from 2014-2020

Figure Middle East & Africa Endometrial Cancer Therapeutics Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Endometrial Cancer Therapeutics Import and Export from 2014-2020

Table Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Endometrial Cancer Therapeutics Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Endometrial Cancer Therapeutics Participants Value ($) and Market Share (%) in 2019

Table Eli Lilly and Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Eli Lilly and Company Sales and Growth Rate from 2014-2020

Figure Eli Lilly and Company Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table F. Hoffman La Roche Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure F. Hoffman La Roche Ltd. Sales and Growth Rate from 2014-2020

Figure F. Hoffman La Roche Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table CELGENE Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure CELGENE Sales and Growth Rate from 2014-2020

Figure CELGENE Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Merck KGaA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Merck KGaA Sales and Growth Rate from 2014-2020

Figure Merck KGaA Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table ArQule, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure ArQule, Inc. Sales and Growth Rate from 2014-2020

Figure ArQule, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bayer AG Sales and Growth Rate from 2014-2020

Figure Bayer AG Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sanofi Sales and Growth Rate from 2014-2020

Figure Sanofi Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Janssen Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Janssen Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Janssen Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Sales and Growth Rate from 2014-2020

Figure Pfizer Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Bristol-Myers Squibb Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bristol-Myers Squibb Company Sales and Growth Rate from 2014-2020

Figure Bristol-Myers Squibb Company Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Takeda Pharmaceutical Company Limited Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Takeda Pharmaceutical Company Limited Sales and Growth Rate from 2014-2020

Figure Takeda Pharmaceutical Company Limited Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GlaxoSmithKline plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GlaxoSmithKline plc Sales and Growth Rate from 2014-2020

Figure GlaxoSmithKline plc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Novartis Sales and Growth Rate from 2014-2020

Figure Novartis Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Endometrial Cancer Therapeutics Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Endometrial Cancer Therapeutics Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Endometrial Cancer Therapeutics Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Endometrial Cancer Therapeutics Production and Growth Rate Forecast by Types (2021-2026)

Table Global Endometrial Cancer Therapeutics Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390